https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dabrafenib-combination-trametinib-unresectable-or-metastatic-solid?sf166541819=1
FDA grants accelerated approval to dabrafenib in combination with trametinib for unresectable or metastatic solid tumors with BRAF V600E mutation
accelerated approvalin combinationfdagrantsdabrafenib
https://sciencedaily.com/releases/2025/05/250528132123.htm
Researchers have discovered that the combination of the two cancer drugs Rapamycin and Trametinib significantly extends the lifespan of mice. This therapy...
combination therapyrapamycintrametiniblife